Skip to main content
OpenTrials

Clinical trial condition

Ann Arbor Stage IV Grade 2 Follicular Lymphoma

Explore clinical trials studying Ann Arbor Stage IV Grade 2 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

8 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Ann Arbor Stage IV Grade 2 Follicular Lymphoma trial results

Completed

Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma

NCT01286272

Conditions
Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +4 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Saint Helena Hospital St. Helena, California, United States
  • Middlesex Hospital Middletown, Connecticut, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 96 locations
View Trial Details
Completed

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT01145495

Conditions
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, +9 more
Locations
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
  • Palo Alto Medical Foundation Health Care Palo Alto, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

NCT01829568

Conditions
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, +9 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions